Dupont Capital Management’s Avanos Medical AVNS Stock Holding History

Dupont Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-7,900	Closed	-$301K	–	946
2017 Q1	$301K	Buy	+7,900	New	+$308K	0.01%	787
2016 Q4	–	Sell	-20,623	Closed	-$715K	–	813
2016 Q3	$715K	Buy	20,623 +7,560	+58%	+$265K	0.02%	521
2016 Q2	$425K	Buy	+13,063	New	+$400K	0.01%	599
2015 Q1	–	Sell	-1,062	Closed	-$48K	–	570
2014 Q4	$48K	Buy	+1,062	New	+$41.7K	﹤0.01%	590

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Dupont Capital Management's AVNS Position: Q2 2017 in Review

Dupont Capital Management sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 7,900 shares — an estimated $301K sold.

Dupont Capital Management first reported a position in AVNS in Q4 2014 and held it in 4 quarters. The position peaked at $715K in Q3 2016. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

Dupont Capital Management reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
Dupont Capital Management sold 7,900 Avanos Medical shares in Q2 2017, an estimated $301K.
Dupont Capital Management first reported a position in Avanos Medical in Q4 2014 and held it in 4 quarters.
Dupont Capital Management's Avanos Medical position peaked at $715K in Q3 2016.
328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Dupont Capital Management's 13F filing for Q2 2017, filed 3 Aug 2017.